Detlef Thomas Haase


Ontology type: schema:Person     


Person Info

NAME

Detlef Thomas

SURNAME

Haase

Publications in SciGraph latest 50 shown

  • 2021-05-04 Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes in NATURE MEDICINE
  • 2021-04-27 Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q) in ANNALS OF HEMATOLOGY
  • 2021-02-09 Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes in NATURE MEDICINE
  • 2020-08-03 Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes in NATURE MEDICINE
  • 2020-06-29 Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS in LEUKEMIA
  • 2020-02-17 Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7 in LEUKEMIA
  • 2019-01-11 TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups in LEUKEMIA
  • 2018-06-06 Cytogenetics of MDS in MYELODYSPLASTIC SYNDROMES
  • 2018-03-07 Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders in BLOOD CANCER JOURNAL
  • 2017-04-03 Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial in ANNALS OF HEMATOLOGY
  • 2016-08-10 Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q in ANNALS OF HEMATOLOGY
  • 2015-12-15 Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) in LEUKEMIA
  • 2013-11-04 Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients in LEUKEMIA
  • 2013-06-21 Monosomal karyotype in MDS: explaining the poor prognosis? in LEUKEMIA
  • 2013-01-28 Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study in LEUKEMIA
  • 2012-10-17 Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload in ANNALS OF HEMATOLOGY
  • 2012-02-06 Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group in LEUKEMIA
  • 2011-04-08 Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid in CLINICAL EPIGENETICS
  • 2011-03-12 Cytogenetics of MDS in THE MYELODYSPLASTIC SYNDROMES
  • 2010-06-22 Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group in ANNALS OF HEMATOLOGY
  • 2009-01-16 Meeting report: Vienna 2008 Workshop of the German–Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes in ANNALS OF HEMATOLOGY
  • 2008-04-15 Cytogenetic features in myelodysplastic syndromes in ANNALS OF HEMATOLOGY
  • 2006-01-26 Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial in LEUKEMIA
  • 2005-09-29 Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS) in LEUKEMIA
  • 2005-03-10 Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia in LEUKEMIA
  • 2004-09 Therapieinduzierte hämatologische Neoplasien nach Mammakarzinomen in MEDIZINISCHE KLINIK
  • 2003 Myelodysplastische Syndrome in MOLEKULARMEDIZINISCHE GRUNDLAGEN VON HÄMATOLOGISCHEN NEOPLASIEN
  • 2003 Proliferative Activity of Leukemic Blasts and Cytosine Arabinoside Pharmacodynamics are Associated with Cytogenetically Defined Prognostic Subgroups in Acute Myeloid Leukemia in ACUTE LEUKEMIAS IX
  • 2001-03-01 Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF in LEUKEMIA
  • 2001-02 Effects of amifostine in a patient with an advanced-stage myelodysplastic syndrome in ANNALS OF HEMATOLOGY
  • 2001 Molecular Characterization of the Translocation (10;11)(p13;q14): MLLandCALMare Fused toAF10in Morphologically Different Subsets of Acute Leukemia in ACUTE LEUKEMIAS VIII
  • 2001 MLL-Duplications are Rare and Associated with Poor Prognosis in Acute Myeloid Leukemia in ACUTE LEUKEMIAS VIII
  • 2000-08 Isolated meningeal chloroma (granulocytic sarcoma) – a case report and review of the literature in ANNALS OF HEMATOLOGY
  • 2000-08-01 Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia in LEUKEMIA
  • 2000-04-28 Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML in LEUKEMIA
  • 1999-05 Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 1999-03-01 Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission in LEUKEMIA
  • 1998-05 Hemoglobin F in myelodysplastic syndrome in ANNALS OF HEMATOLOGY
  • 1998 G-CSF Increases the Number of Trisomy 8 Metaphases in Vitro in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in ACUTE LEUKEMIAS VII
  • 1998 The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis? in ACUTE LEUKEMIAS VII
  • 1998 The Karyotype in MDS — Cytogenetic Profile, Clinical Correlations and Prognostic Implications in 362 Patients with MDS in ACUTE LEUKEMIAS VII
  • 1998 Intensified Therapy for AML:The Role of the HAM Combination in ACUTE LEUKEMIAS VII
  • 1998 Biologic Determinants for AML Therapy in ACUTE LEUKEMIAS VII
  • 1998 Clonal Chromosomal Abnormalities in the Stem Cell Compartment of a Patient with Acute Myeloid Leukemia in Hematological Complete Remission in ACUTE LEUKEMIAS VII
  • 1998 Involvement of CD34+ Stem Cells in Malignant Transformation in AML and MDS — Genetic Analysis of Sorted Subpopulations by Classical and Molecular Cytogenetics in ACUTE LEUKEMIAS VII
  • 1997-06 Induction of a hematological and cytogenetic remission in a patient with a myelodysplastic syndrome secondary to Fanconi's anemia employing the S-HAM regimen in ANNALS OF HEMATOLOGY
  • 1997-05-01 Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117 in LEUKEMIA
  • 1997 Chromosome Abnormalities and Karyotype Evolution in the Stem Cell Compartments of AML and MDS in ACUTE LEUKEMIAS VI
  • 1997 Detection of Minimal Residual Disease in Cytogenetically Defined Prognostic Subgroups of AML in ACUTE LEUKEMIAS VI
  • 1997 Genetic Instability and Evolution of Karyotype in Secondary Acute Myeloid Leukemia in ACUTE LEUKEMIAS VI
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.411984.1", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.430269.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.22937.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411937.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5963.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419842.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14778.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4562.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10423.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414473.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411095.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6936.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5802.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.499820.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410712.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412468.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411327.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7450.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5949.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5361.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413662.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410718.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410706.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15090.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5252.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7497.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.248762.d", 
            "type": "Organization"
          }
        ], 
        "familyName": "Haase", 
        "givenName": "Detlef Thomas", 
        "id": "sg:person.0754465332.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754465332.53"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-09-02T16:35", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/person/person_855.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0754465332.53'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0754465332.53'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0754465332.53'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0754465332.53'


     

    This table displays all metadata directly associated to this object as RDF triples.

    70 TRIPLES      10 PREDICATES      38 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0754465332.53 schema:affiliation N408f45f1518644cd8b66e0a293320828
    2 grid-institutes:grid.10423.34
    3 grid-institutes:grid.14778.3d
    4 grid-institutes:grid.15090.3d
    5 grid-institutes:grid.22937.3d
    6 grid-institutes:grid.240145.6
    7 grid-institutes:grid.248762.d
    8 grid-institutes:grid.410706.4
    9 grid-institutes:grid.410712.1
    10 grid-institutes:grid.410718.b
    11 grid-institutes:grid.411095.8
    12 grid-institutes:grid.411327.2
    13 grid-institutes:grid.411937.9
    14 grid-institutes:grid.412468.d
    15 grid-institutes:grid.413662.4
    16 grid-institutes:grid.414473.1
    17 grid-institutes:grid.419842.2
    18 grid-institutes:grid.430269.a
    19 grid-institutes:grid.4562.5
    20 grid-institutes:grid.499820.e
    21 grid-institutes:grid.5252.0
    22 grid-institutes:grid.5361.1
    23 grid-institutes:grid.5802.f
    24 grid-institutes:grid.5949.1
    25 grid-institutes:grid.5963.9
    26 grid-institutes:grid.6936.a
    27 grid-institutes:grid.7450.6
    28 grid-institutes:grid.7497.d
    29 schema:familyName Haase
    30 schema:givenName Detlef Thomas
    31 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754465332.53
    32 schema:sdDatePublished 2022-09-02T16:35
    33 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    34 schema:sdPublisher N2c154bdb906c40de9e88ab47cca43d5b
    35 sgo:license sg:explorer/license/
    36 sgo:sdDataset persons
    37 rdf:type schema:Person
    38 N2c154bdb906c40de9e88ab47cca43d5b schema:name Springer Nature - SN SciGraph project
    39 rdf:type schema:Organization
    40 N408f45f1518644cd8b66e0a293320828 schema:affiliation grid-institutes:grid.411984.1
    41 sgo:isCurrent true
    42 rdf:type schema:OrganizationRole
    43 grid-institutes:grid.10423.34 schema:Organization
    44 grid-institutes:grid.14778.3d schema:Organization
    45 grid-institutes:grid.15090.3d schema:Organization
    46 grid-institutes:grid.22937.3d schema:Organization
    47 grid-institutes:grid.240145.6 schema:Organization
    48 grid-institutes:grid.248762.d schema:Organization
    49 grid-institutes:grid.410706.4 schema:Organization
    50 grid-institutes:grid.410712.1 schema:Organization
    51 grid-institutes:grid.410718.b schema:Organization
    52 grid-institutes:grid.411095.8 schema:Organization
    53 grid-institutes:grid.411327.2 schema:Organization
    54 grid-institutes:grid.411937.9 schema:Organization
    55 grid-institutes:grid.411984.1 schema:Organization
    56 grid-institutes:grid.412468.d schema:Organization
    57 grid-institutes:grid.413662.4 schema:Organization
    58 grid-institutes:grid.414473.1 schema:Organization
    59 grid-institutes:grid.419842.2 schema:Organization
    60 grid-institutes:grid.430269.a schema:Organization
    61 grid-institutes:grid.4562.5 schema:Organization
    62 grid-institutes:grid.499820.e schema:Organization
    63 grid-institutes:grid.5252.0 schema:Organization
    64 grid-institutes:grid.5361.1 schema:Organization
    65 grid-institutes:grid.5802.f schema:Organization
    66 grid-institutes:grid.5949.1 schema:Organization
    67 grid-institutes:grid.5963.9 schema:Organization
    68 grid-institutes:grid.6936.a schema:Organization
    69 grid-institutes:grid.7450.6 schema:Organization
    70 grid-institutes:grid.7497.d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...